Comparison of the effect on glycemic control of biphasic insulin aspart 70/30 [insulin aspart/insulin protamine aspart] versus insulin glargine in combination with metformin in subjects with type 2 diabetes.
Phase of Trial: Phase III
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 20 May 2009 Actual end date (1 Nov 2006) and actual patient number (293) added as reported by ClinicalTrials.gov.
- 05 Sep 2007 Status changed from in progress to completed.